Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer
Mar. 14, 2018—New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers.
Jan. 8, 2018—Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.
Aug. 30, 2017—Carlos F. Lopez, assistant professor of biochemistry and biomedical informatics, has been appointed as Vanderbilt University's liaison to Oak Ridge National Laboratory.
Jun. 22, 2016—Provost and Vice Chancellor for Academic Affairs Susan R. Wente has appointed an 18-member committee of faculty and students to conduct the national search for the Barlow Family Director of the Vanderbilt Brain Institute chaired by Randolph Blake, Centennial Professor of Psychology, and Danny Winder, director for the Vanderbilt Center for Addiction Research.
May. 9, 2016—A national search will be launched this fall for the Barlow Family Director of the Vanderbilt Brain Institute, Provost and Vice Chancellor for Academic Affairs Susan R. Wente announced today. Current VBI Associate Director Ron Emeson will begin a term as interim director effective July 1.